ロード中...
Canada’s highest court unchains injection drug users; implications for harm reduction as standard of healthcare
North America’s only supervised injection facility, Insite, opened its doors in September of 2003 with a federal exemption as a three-year scientific study. The results of the study, evaluated by an independent research team, showed it to be successful in engaging the target group in healthcare, pre...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3492113/ https://ncbi.nlm.nih.gov/pubmed/22817679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7517-9-34 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|